Table 3.
Area under the curve (AUC) for discriminating all malignant cases from benign cases.
| Variables | AUC | 95% CI | Cut-off | Sensitivity (%) | Specificity (%) |
|---|---|---|---|---|---|
| CA125 (U/mL) | 90.6 | 88.5-92.8 | 35 | 89.5 | 70.9 |
| HGB (g/L) | 59.9 | 55.7-64.0 | 124.5 | 45.1 | 71.0 |
| MCV (Fl) | 56.2 | 51.9-60.6 | 87.15 | 31.0 | 80.7 |
| HCT (%) | 56.8 | 52.5-61.0 | 38.95 | 54.9 | 57.0 |
| WBC (10^9/L) | 63.6 | 59.4-67.8 | 5.815 | 69.5 | 52.4 |
| NLR | 74.9 | 71.4-78.4 | 2.139 | 67.6 | 71.8 |
| PLR | 73.0 | 69.6-76.4 | 182.698 | 51.1 | 86.5 |
| LMR | 70.9 | 67.2-74.5 | 3.619 | 53.6 | 83.0 |
CA125, Cancer Antigen 125; HGB, hemoglobin concentration; MCV, mean corpuscular volume; HCT, hematocrit; WBC, white blood cell count; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; LMR, lymphocyte-to-monocyte ratio.